世界のバイオマーカー市場...市場調査レポートについてご紹介

【英文タイトル】Biomarkers Market - ([Discovery Technologies - Proteomics, Genomics, Imaging, Bioinformatics], Validation Services, Applications [drug development, personalized medicine], Diseases [Oncology, Cardiology, Neurology]) - Global Trends & Forecasts (2013-2018)

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

TABLE OF CONTENTS

1 INTRODUCTION
1.1 KEY TAKE-AWAYS
1.2 REPORT DESCRIPTION
1.3 STAKEHOLDERS
1.4 RESEARCH METHODOLOGY
1.4.1 MARKET SIZE
1.4.2 KEY DATA POINTS FROM SECONDARY SOURCES
1.4.3 ASSUMPTIONS

2 EXECUTIVE SUMMARY

3 MARKET OVERVIEW
3.1 DEFINITION OF BIOMARKERS
3.2 BIOMARKERS & ITS TYPES
3.3 BIOMARKERS MARKET
3.3.1 MARKET SEGMENTATION
3.3.2 CHALLENGES & OPPORTUNITIES
3.3.2.1 Challenges
3.3.2.1.1 Variability
3.3.2.1.2 Ethical considerations & acceptability
3.3.2.2 Opportunities
3.3.2.2.1 Personalized medicine
3.3.2.2.2 Companion diagnostics
3.3.3 DRIVERS & RESTRAINTS
3.3.3.1 Drivers
3.3.3.1.1 High demand boosts the growth of the biomarkers market globally
3.3.3.1.2 Strategic collaborations lead to increasing applications in the market
3.3.3.1.3 Technological advances contribute to growth
3.3.3.1.4 The rising prevalence of the disease forms
3.3.3.1.5 FDA support for biomarkers development
3.3.3.2 Restraints
3.3.3.2.1 Low capital investment & cost-benefit hinders growth of biomarkers
3.3.3.2.2 Biomarkers not a profitable market for small organizations
3.3.3.2.3 Sample collection & storage
3.3.3.2.4 Limited biomarkers validation
3.3.3.2.5 Need for new R&D models with greater precision & flexibility

4 GLOBAL BIOMARKERS MARKET, BY DISCOVERY TECHNOLOGIES
4.1 INTRODUCTION
4.2 IMAGING TECHNOLOGIES FOR BIOMARKERS DISCOVERY
4.2.1 POSITRON EMISSION TOMOGRAPHY (PET)
4.2.2 SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY(SPECT)
4.2.3 ULTRASOUND
4.2.4 MAGNETIC RESONANCE IMAGING (MRI)
4.2.5 COMPUTED TOMOGRAPHY (CT)
4.3 OMICS TECHNOLOGIES FOR BIOMARKERS DISCOVERY
4.3.1 PROTEOMICS
4.3.1.1 Mass spectrometry
4.3.1.1.1 MALDI mass spectrometry
4.3.1.1.2 Imaging mass spectrometry
4.3.1.2 2D Gel Electrophoresis
4.3.1.3 Protein microarray technology
4.3.1.4 Antibody array technology
4.3.1.5 Peptide array technology
4.3.2 GENOMICS
4.3.2.1 Whole genome sequencing
4.3.2.2 Genotyping
4.3.2.3 Epigenetics
4.3.3 TRANSCRIPTOMICS
4.3.3.1 Microarrays
4.3.3.2 Gene expression profiling
4.3.4 METABOLOMICS
4.3.4.1 Capillary electrophoresis
4.3.4.2 Mass spectrometry based kits
4.3.4.3 Nuclear Magnetic Resonance(NMR)
4.4 BIOINFORMATICS
4.4.1 CLUSTER ANALYSIS
4.4.2 STATISTICAL ANALYSIS
4.4.3 CELL SIGNAL PATHWAYS
4.4.4 COMPUTER AIDED DESIGN
4.4.5 DATA MINING
4.4.6 PROTEIN INTERACTION MAPS

5 SERVICES MARKET OF BIOMARKERS
5.1 INTRODUCTION
5.2 CLINICAL
5.2.1 SAMPLE PREPARATION
5.2.2 ASSAY DEVELOPMENT
5.2.3 BIOMARKERS VALIDATION & TESTING
5.2.3.1 Feasibility Studies and choice of assay & biomarkers
5.2.3.2 Long lead time required for Biomarkers Assay preparation
5.3 BIOINFORMATICS
5.3.1 FUNCTIONAL GENOMICS & PROTEOMICS DRIVE THE DEMAND FOR BIOINFORMATICS

6 BIOMARKERS APPLICATION MARKET
6.1 INTRODUCTION
6.2 DRUG DISCOVERY & DEVELOPMENT
6.2.1 CLINICAL TRIALS
6.2.1.1 Preclinical Development
6.2.1.2 Phase I drug development
6.2.1.3 Phase II drug development
6.2.1.4 Phase III drug development
6.2.1.5 Phase IV drug development
6.3 PERSONALIZED MEDICINE
6.4 MOLECULAR DIAGNOSTICS
6.4.1 MOLECULAR DIAGNOSTICS IS A DYNAMIC & RAPIDLY BROADENING MARKET
6.4.2 TRENDS IN THE DIAGNOSTICS MARKET
6.4.3 CHALLENGES
6.4.3.1 Nucleic acids pose a challenge to the molecular diagnostics field
6.4.3.2 Molecular diagnostics market lacks a collaborated effort
6.4.4 DRIVER
6.4.4.1 Increase in the incidence of diseases spurs the growth of the diagnostics market
6.4.5 RESTRAINT
6.4.5.1 The “interest-information” restricts growth of molecular diagnostics
6.4.6 MOLECULAR DIAGNOSTICS IN MAJOR INDICATIONS
6.4.6.1 Oncology
6.4.6.2 Cardiology
6.4.6.3 Neurology
6.4.6.4 Other treatment areas
6.4.7 BIOMARKERS IN DIAGNOSTICS
6.4.8 BENEFITS OF MOLECULAR DIAGNOSTICS

7 BIOMARKERS INDICATION MARKET
7.1 INTRODUCTION
7.2 ONCOLOGY BIOMARKERS MARKET
7.2.1 ONCOLOGY BIOMARKERS DISCOVERY MARKET
7.2.1.1 Genomics
7.2.1.2 Proteomics
7.2.1.3 Metabolomics
7.2.1.4 Transcriptomics
7.2.1.5 Other Omics
7.2.1.6 Imaging
7.2.2 DRUG DISCOVERY & DEVELOPMENT
7.2.3 CANCER TYPES
7.2.3.1 Ovarian Cancer
7.2.3.2 Breast Cancer
7.2.3.3 Bladder Cancer
7.2.3.4 Cervical Cancer
7.2.3.5 Prostate Cancer
7.2.3.6 Lung Cancer
7.2.3.7 Colorectal Cancer
7.3 CARDIOLOGY BIOMARKERS MARKET
7.3.1 CARDIOLOGY BIOMARKERS DISCOVERY MARKET
7.3.1.1 Genomics
7.3.1.2 Proteomics
7.3.1.3 Metabolomics
7.3.1.4 Transcriptomics
7.3.1.5 Imaging
7.3.1.6 Bioinformatics
7.3.2 DRUG DISCOVERY & DEVELOPMENT
7.3.3 CARDIAC MARKERS, BY DISEASE TYPES
7.3.3.1 Acute Coronary Syndrome
7.3.3.2 Coronary artery disease
7.3.3.3 Stroke
7.3.4 CARDIOLOGY BIOMARKERS USED IN THE MARKET
7.4 NEUROLOGY BIOMARKERS MARKET
7.4.1 NEUROLOGY BIOMARKERS DISCOVERY MARKET
7.4.1.1 Omics technologies
7.4.1.2 Imaging Technologies
7.4.2 DRUG DISCOVERY & DEVELOPMENT
7.4.3 DISEASE TYPES
7.4.3.1 Alzheimer’s disease
7.4.3.2 Parkinson’s disease
7.4.3.3 Multiple sclerosis
7.4.3.4 Schizophrenia
7.4.3.5 Amyotrophic Lateral Sclerosis
7.4.3.6 Epilepsy
7.5 OTHER INDICATIONS BIOMARKERS MARKET
7.5.1 OTHER INDICATION BIOMARKERS DISCOVERY MARKET
7.5.1.1 Omics technologies
7.5.1.2 Imaging technologies
7.5.2 DRUG DISCOVERY & DEVELOPMENT
7.6 DISEASE TYPES
7.6.1 HIV
7.6.1.1 Immunological & Virological Markers in HIV Infection
7.7 RENAL FAILURE
7.8 ARTHRITIS
7.9 TUBERCULOSIS
7.10 DIABETES

8 GEOGRAPHICAL ANALYSIS
8.1 INTRODUCTION
8.2 NORTH AMERICA
8.3 EUROPE
8.4 ASIA
8.5 ROW

9 COMPETITIVE LANDSCAPE
9.1 KEY STRATEGIES
9.2 MERGERS & ACQUISITIONS
9.3 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS & JOINT VENTURES
9.4 NEW PRODUCTS LAUNCH
9.5 OTHER DEVELOPMENTS

10 COMPANY PROFILES
10.1 ABBOTT LABORATORIES
10.1.1 OVERVIEW
10.1.2 FINANCIALS
10.1.3 PRODUCTS & SERVICES
10.1.4 STRATEGY
10.1.5 DEVELOPMENTS
10.2 ABCODIA LTD
10.2.1 OVERVIEW
10.2.2 FINANCIALS
10.2.3 PRODUCTS & SERVICES
10.2.4 STRATEGY
10.2.5 DEVELOPMENTS
10.3 AFFYMETRIX INC
10.3.1 OVERVIEW
10.3.2 FINANCIALS
10.3.3 PRODUCTS & SERVICES
10.3.4 STRATEGY
10.3.5 DEVELOPMENTS
10.4 AGILENT TECHNOLOGIES INC
10.4.1 OVERVIEW
10.4.2 FINANCIALS
10.4.3 PRODUCTS & SERVICES
10.4.4 STRATEGY
10.4.5 DEVELOPMENTS
10.5 AMGEN INC
10.5.1 OVERVIEW
10.5.2 FINANCIALS
10.5.3 PRODUCTS & SERVICES
10.5.4 STRATEGY
10.5.5 DEVELOPMENT
10.6 ASTRAZENECA PLC
10.6.1 OVERVIEW
10.6.2 FINANCIALS
10.6.3 PRODUCTS & SERVICES
10.6.4 STRATEGY
10.6.5 DEVELOPMENTS
10.7 AUGUREX LIFE SCIENCES CORP
10.7.1 OVERVIEW
10.7.2 FINANCIALS
10.7.3 PRODUCTS & SERVICES
10.7.4 STRATEGY
10.7.5 DEVELOPMENTS
10.8 AUSHON BIOSYSTEMS INC
10.8.1 OVERVIEW
10.8.2 FINANCIALS
10.8.3 PRODUCTS & SERVICES
10.8.4 STRATEGY
10.8.5 DEVELOPMENTS
10.9 BAYER AG
10.9.1 OVERVIEW
10.9.2 FINANCIALS
10.9.3 PRODUCTS & SERVICES
10.9.4 STRATEGY
10.9.5 DEVELOPMENTS
10.1 BECKMAN COULTER INC
10.10.1 OVERVIEW
10.10.2 FINANCIALS
10.10.3 PRODUCTS & SERVICES
10.10.4 STRATEGY
10.10.5 DEVELOPMENTS
10.11 BGI
10.11.1 OVERVIEW
10.11.2 FINANCIALS
10.11.3 PRODUCTS & SERVICES
10.11.4 STRATEGY
10.11.5 DEVELOPMENTS
10.12 BIOCRATES LIFE SCIENCES AG
10.12.1 OVERVIEW
10.12.2 FINANCIALS
10.12.3 PRODUCTS & SERVICES
10.12.4 STRATEGY
10.12.5 DEVELOPMENTS
10.13 BIOMARKERS STRATEGIES
10.13.1 OVERVIEW
10.13.2 FINANCIALS
10.13.3 PRODUCTS & SERVICES
10.13.4 STRATEGY
10.13.5 DEVELOPMENTS
10.14 BIOSYSTEMS INTERNATIONAL
10.14.1 OVERVIEW
10.14.2 FINANCIALS
10.14.3 PRODUCTS & SERVICES
10.14.4 STRATEGY
10.14.5 DEVELOPMENTS
10.15 BRISTOL-MYERS SQUIBB
10.15.1 OVERVIEW
10.15.2 FINANCIALS
10.15.3 PRODUCTS & SERVICES
10.15.4 STRATEGY
10.15.5 DEVELOPMENTS
10.16 CRESCENDO BIOSCIENCE
10.16.1 OVERVIEW
10.16.2 FINANCIALS
10.16.3 PRODUCTS & SERVICES
10.16.4 STRATEGY
10.16.5 DEVELOPMENTS
10.17 EISAI CO. LTD.
10.17.1 OVERVIEW
10.17.2 FINANCIALS
10.17.3 PRODUCTS & SERVICES
10.17.4 STRATEGY
10.17.5 DEVELOPMENTS
10.18 EPIONTIS GMBH
10.18.1 OVERVIEW
10.18.2 FINANCIALS
10.18.3 PRODUCTS & SERVICES
10.18.4 DEVELOPMENTS
10.19 EPISTEM HOLDINGS PLC
10.19.1 OVERVIEW
10.19.2 FINANCIALS
10.19.3 PRODUCTS & SERVICES
10.19.4 STRATEGY
10.19.5 DEVELOPMENTS
10.20 EUROGENTEC S.A.
10.20.1 OVERVIEW
10.20.2 FINANCIALS
10.20.3 PRODUCTS & SERVICES
10.20.4 STRATEGY
10.20.5 DEVELOPMENTS
10.21 EVOTEC AG
10.21.1 OVERVIEW
10.21.2 FINANCIALS
10.21.3 PRODUCTS & SERVICES
10.21.4 STRATEGY
10.21.5 DEVELOPMENTS
10.22 GLAXOSMITHKLINE PLC
10.22.1 OVERVIEW
10.22.2 FINANCIALS
10.22.3 PRODUCTS & SERVICES
10.22.4 STRATEGY
10.22.5 DEVELOPMENTS
10.23 IPSEN
10.23.1 OVERVIEW
10.23.2 FINANCIALS
10.23.3 PRODUCTS & SERVICES
10.23.4 STRATEGY
10.23.5 DEVELOPMENTS
10.24 JOHNSON & JOHNSON
10.24.1 OVERVIEW
10.24.2 FINANCIALS
10.24.3 PRODUCTS & SERVICES
10.24.4 STRATEGY
10.24.5 DEVELOPMENTS
10.25 MERCK & CO.
10.25.1 OVERVIEW
10.25.2 FINANCIALS
10.25.3 PRODUCTS & SERVICES
10.25.4 STRATEGY
10.25.5 DEVELOPMENTS
10.26 MICROMEDIC TECHNOLOGIES LTD
10.26.1 OVERVIEW
10.26.2 PRODUCTS & SERVICES
10.26.3 STRATEGY
10.26.4 DEVELOPMENTS
10.27 MYRIAD GENETICS INC
10.27.1 OVERVIEW
10.27.2 FINANCIALS
10.27.3 PRODUCTS & SERVICES
10.27.4 STRATEGY
10.27.5 DEVELOPMENTS
10.28 NEXTGEN SCIENCES INC
10.28.1 OVERVIEW
10.28.2 FINANCIALS
10.28.3 PRODUCTS & SERVICES
10.28.4 STRATEGY
10.28.5 DEVELOPMENTS
10.29 NOVARTIS INTERNATIONAL AG
10.29.1 OVERVIEW
10.29.2 FINANCIALS
10.29.3 PRODUCTS & SERVICES
10.29.4 STRATEGY
10.29.5 DEVELOPMENTS
10.30 OCIMUM BIOSOLUTIONS LTD
10.30.1 OVERVIEW
10.30.2 FINANCIALS
10.30.3 PRODUCTS & SERVICES
10.30.4 STRATEGY
10.30.5 DEVELOPMENTS
10.31 PFIZER INC
10.31.1 OVERVIEW
10.31.2 FINANCIALS
10.31.3 PRODUCTS & SERVICES
10.31.4 STRATEGY
10.31.5 DEVELOPMENTS
10.32 PRONOTA NV
10.32.1 OVERVIEW
10.32.2 FINANCIALS
10.32.3 PRODUCTS & SERVICES
10.32.4 STRATEGY
10.32.5 DEVELOPMENTS
10.33 QUINTILES TRANSNATIONAL CORPORATION
10.33.1 OVERVIEW
10.33.2 FINANCIALS
10.33.3 PRODUCTS & SERVICES
10.33.4 STRATEGY
10.33.5 DEVELOPMENTS
10.34 QIAGEN NV
10.34.1 OVERVIEW
10.34.2 FINANCIALS
10.34.3 PRODUCTS & SERVICES
10.34.4 STRATEGY
10.34.5 DEVELOPMENTS
10.35 ROCHE DIAGNOSTICS LIMITED
10.35.1 OVERVIEW
10.35.2 FINANCIALS
10.35.3 PRODUCTS & SERVICES
10.35.4 STRATEGY
10.35.5 DEVELOPMENT
10.36 SANOFI-AVENTIS
10.36.1 OVERVIEW
10.36.2 FINANCIALS
10.36.3 PRODUCTS & SERVICES
10.36.4 STRATEGY
10.36.5 DEVELOPMENT
10.37 SIEMENS HEALTHCARE
10.37.1 OVERVIEW
10.37.2 FINANCIALS
10.37.3 PRODUCTS & SERVICES
10.37.4 STRATEGY
10.37.5 DEVELOPMENTS
10.38 TRANS-HIT BIOMARKERS INC
10.38.1 OVERVIEW
10.38.2 FINANCIALS
10.38.3 PRODUCTS & SERVICES
10.38.4 STRATEGY
10.38.5 DEVELOPMENTS
10.39 PACIFIC BIOMARKERS INC
10.39.1 OVERVIEW
10.39.2 FINANCIALS
10.39.3 PRODUCTS & SERVICES
10.39.4 STRATEGY
10.39.5 DEVELOPMENTS
10.40 CAPRION PROTEOMICS INC.
10.40.1 OVERVIEW
10.40.2 FINANCIALS
10.40.3 PRODUCTS & SERVICES
10.40.4 STRATEGY
10.40.5 DEVELOPMENTS
10.41 PROTEOME SCIENCES PLC
10.41.1 OVERVIEW
10.41.2 FINANCIALS
10.41.3 PRODUCTS & SERVICES
10.41.4 STRATEGY
10.41.5 DEVELOPMENTS
10.42 VERMILLION INC
10.42.1 OVERVIEW
10.42.2 FINANCIALS
10.42.3 PRODUCTS & SERVICES
10.42.4 STRATEGY
10.42.5 DEVELOPMENTS


【レポート販売概要】

■ タイトル:世界のバイオマーカー市場
■ 英文:Biomarkers Market - ([Discovery Technologies - Proteomics, Genomics, Imaging, Bioinformatics], Validation Services, Applications [drug development, personalized medicine], Diseases [Oncology, Cardiology, Neurology]) - Global Trends & Forecasts (2013-2018)
■ 発行日:2013年9月
■ 調査会社:MarketsandMarkets
■ 商品コード:BT 2120
■ 調査対象地域:グローバル
  • 世界のパッケージドLED市場2015
    The Global Packaged LED Industry Report 2015 is a professional and in-depth study on the current state of the Packaged LED industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Packaged LED market analysis is provided for the international markets including development trends, competitive landscape anal …
  • 家庭用電気フライヤーの世界市場
    ABSTRACTAbout Residential Electric Fryer Electric fryers are considered as small kitchen appliances that are used for frying food items. Some electric fryers are also used for baking, roasting, and grilling. Within cooking appliances, other than electric fryers, gas fryers are considered as the other segment. The global home appliances market currently registers a healthy growth owing to the growi …
  • MEDRAD, Inc.:市場シェア分析
    MEDRAD, Inc. Market Share Analysis Summary GlobalData’s new report, “MEDRAD, Inc. Market Share Analysis” provides in-depth information on MEDRAD, Inc.’s market position in the contrast media injectors market. The report also provides data and information on the overall competitive landscape within the contrast media injectors market. The report is supplemented with global corporate-level profile w …
  • 世界の実験室プラスチック製器具及びガラス製器具市場動向(2012-2016)
    TechNavio's analysts forecast the Global Laboratory Plasticware and Glassware market to grow at a CAGR of 5.17 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increase in research and development activities. The Global Laboratory Plasticware and Glassware market has also been witnessing the trend of increasing preference of plastic over glass. Ho …
  • 鎮痛薬の世界市場2016-2020
    About the Analgesics Market Analgesics are among the most commonly prescribed drugs for pain, especially that from fractures, ankle sprains, and other injuries. These are designed particularly for pain relief. Opioids, NSAIDs, and local anesthetics are the major analgesics used to treat pain. The long term use of analgesics has been linked to gastrointestinal problems. Pain is treated with analges …
  • 総胆管結石症(Choledocholithiasis):世界の治験レビュー(2015年上半期版)
    Choledocholithiasis Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Choledocholithiasis Global Clinical Trials Review, H1, 2015" provides data on the Choledocholithiasis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Choledocholithiasis. It includes an overview of the trial numbers and their recru …
  • ビタミンDの世界市場2018-2022
    About this market Though vitamins are not that easy for the consumer to shop online without prior extensive product knowledge, still online sales of vitamins have increased dramatically. The major reason for this has been retailers focused efforts on improving the online shopping experience through better online education and targeted marketing. The increases the comfort level of consumers who are …
  • Market Opportunity: Mobile Phone Augmented Reality
    Augmented Reality (AR) via a mobile phone refers to augmentation of what the end-user views with the screen. This is based on overlaying data onto the screen view, which may present a view of the real-world via the camera and points of interest and/or information that is put into the view, virtually, but not really existing in the real-world. AR represents a potential large opportunity for 4G (and …
  • Liver Cancer:グローバル臨床試験レビューH2, 2013
    Liver Cancer Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Liver Cancer Global Clinical Trials Review, H2, 2013" provides data on the Liver Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Liver Cancer. It includes an overview of the trial numbers and their recruitment status as per the sit …
  • 眺望・園芸サービスの世界市場2017-2021
    About Landscaping and Gardening Services Market Landscaping refers to any activity that beautifies vacant land, exteriors or interiors of a building, or public spaces such as parks and gardens. This beautification can be achieved through modifying features (including flora and fauna), construction of terrains and water bodies, and artificial lighting. The global landscaping and gardening services …
  • 認知症(Dementia)の治療薬パイプライン動向(2015年上半期版)
    Dementia - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Dementia - Pipeline Review, H1 2015’, provides an overview of the Dementia’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Dementia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administr …
  • 生体材料(バイオマテリアル)の世界市場予測(~2021):材料種類別(金属、セラミック、ポリマー、天然)、用途別
    The biomaterials market is projected to reach USD 149.17 Billion by 2021 from an estimated USD 70.90 Billion in 2016, at a CAGR of 16.0%. The growth of the overall market can be attributed to increased funds & grants by government bodies worldwide, the growing implantable devices market, technological advancements, rising number of hip and knee replacement procedures, and high growth in geriatric …
  • RSウイルス感染症治療薬の世界市場2016-2020
    About Human Respiratory Syncytial Virus Drugs Respiratory syncytial virus (RSV) is a virus that leads to infections in the lungs and the respiratory tract. It commonly affects most children in the ages 2 or below. RSV can also infect adults. In adults and the older population, the symptoms of RSV are mild and similar to that of common cold. Infection with RSV can be severe in certain cases, partic …
  • 軍事シミュレーション及び仮想訓練の世界市場2017-2021
    About Military Simulation and Virtual TrainingSimulators and virtual training devices are used to reproduce the conditions experienced on the flight deck of aerial platforms, naval vessels, and usage of weapons, target systems, armored vehicles, and missiles exactly. Technavio’s analysts forecast the global military simulation and virtual training market to grow at a CAGR of 4.2% during the period …
  • 非殺傷兵器の世界市場2015-2019
    About non-lethal weapons Non-lethal weapons are used by both the military and law enforcement forces. Unlike lethal weapons that can cause casualties, non-lethal weapons are used to reduce fatalities to a large extent. These weapons are designed to temporarily destabilize the person, with little or no injury. Non-lethal weapons are primarily used for dispersion of crowds, controlling civil wars, a …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。